We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Search Out α-Synuclein Aggregation
Product News

Search Out α-Synuclein Aggregation

Search Out α-Synuclein Aggregation
Product News

Search Out α-Synuclein Aggregation


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Search Out α-Synuclein Aggregation"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

α-synuclein aggregation is a hallmark characteristic of Parkinson’s disease. Recent studies have revealed that microglia, activated by α-synuclein, can produce cytokines that in turn cause neurons to express MHC I. If these neurons express a specific combination of MHC alleles and peptide, they are targeted for destruction by CD8+ T cells. BioLegend provides reagents to specifically identify antigen-specific T cells with our MHC tetramer technology: Flex-T™. In addition, we offer several phospho- and conformation-specific antibodies for the detection of α-synuclein. 

www.biolegend.com/asynuclein_aggregate_Abs

www.biolegend.com/flex-t  

Advertisement